Skip to main content

Table 1 Participant demographics and baseline characteristics in Study 1 and Study 2

From: Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants

 

Study 1

Study 2

FKB327

N = 65

RP

N = 65

FKB327

N = 65

RP

N = 65

Age

Mean (SD)

28.1 (6.96)

28.2 (8.12)

26.5 (7.29)

27.1 (7.56)

BMI

Mean (SD)

21.14 (1.581)

21.15 (1.549)

21.23 (1.905)

21.20 (1.695)

Weight

Mean (SD)

61.92 (6.175)

62.56 (6.412)

61.74 (7.087)

62.09 (6.269)

< 65 kg (n [%])

45 (69.2)

44 (67.7)

46 (70.8)

44 (67.7)

≥65 kg (n [%])

20 (30.8)

21 (32.3)

19 (29.2)

21 (32.3)

  1. BMI Body mass index; RP Reference product; SD Standard deviation